Literature DB >> 2450991

The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse.

B Lang1, J Newsom-Davis, C Peers, C Prior, D W Wray.   

Abstract

1. The action of immunoglobulin G obtained from patients with Lambert-Eaton myasthenic syndrome (LEMS IgG) was investigated by injecting mice, followed by intracellular recordings from the mouse diaphragm. 2. End-plate potential quantal content was studied over a range of Ca2+ concentrations. Curves of log quantal content versus log Ca2+ concentration were shifted to the right by LEMS IgG. For low Ca2+ concentrations, release continued to follow Poisson statistics after LEMS IgG treatment. 3. Miniature end-plate potential (m.e.p.p.) frequency was measured in solutions containing high K+ concentrations. LEMS IgG significantly reduced m.e.p.p. frequency at each K+ concentration studied. 4. M.e.p.p. frequency was measured at fixed high-K+ concentration (15.9 mM) for a range of Ca2+ concentrations. The log-log plot of m.e.p.p. frequency versus Ca2+ concentration was shifted downwards throughout by LEMS IgG. 5. M.e.p.p. frequency was not affected by LEMS IgG in Ca2+-free solutions (K+ concentration 15.9 mM) or in solutions of low Ca2+ concentration (K+ concentration 5.9 mM). 6. At each Ca2+ concentration studied, m.e.p.p. amplitudes were not affected by LEMS IgG. 7. The data suggest that LEMS IgG acts on presynaptic voltage-dependent Ca2+ channels to cause their loss of function, probably by down-regulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2450991      PMCID: PMC1192178          DOI: 10.1113/jphysiol.1987.sp016698

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  15 in total

1.  The nature of the antagonism between calcium and magnesium ions at the neuromuscular junction.

Authors:  D H JENKINSON
Journal:  J Physiol       Date:  1957-10-30       Impact factor: 5.182

2.  Quantal components of the end-plate potential.

Authors:  J DEL CASTILLO; B KATZ
Journal:  J Physiol       Date:  1954-06-28       Impact factor: 5.182

3.  Three types of neuronal calcium channel with different calcium agonist sensitivity.

Authors:  M C Nowycky; A P Fox; R W Tsien
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

4.  Quantal components of end-plate potentials in the myasthenic syndrome.

Authors:  E H Lambert; D Elmqvist
Journal:  Ann N Y Acad Sci       Date:  1971-09-15       Impact factor: 5.691

Review 5.  The biophysical pharmacology of calcium-dependent acetylcholine secretion.

Authors:  E M Silinsky
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

6.  Co-operative action a calcium ions in transmitter release at the neuromuscular junction.

Authors:  F A Dodge; R Rahamimoff
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

7.  Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome.

Authors:  B Lang; J Newsom-Davis; D Wray; A Vincent; N Murray
Journal:  Lancet       Date:  1981-08-01       Impact factor: 79.321

8.  On the calcium receptor that mediates depolarization-secretion coupling at cholinergic motor nerve terminals.

Authors:  E M Silinsky
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

9.  Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones.

Authors:  H Fukunaga; A G Engel; B Lang; J Newsom-Davis; A Vincent
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

10.  Action of Lambert-Eaton myasthenic syndrome IgG at mouse motor nerve terminals.

Authors:  C Prior; B Lang; D Wray; J Newsom-Davis
Journal:  Ann Neurol       Date:  1985-06       Impact factor: 10.422

View more
  21 in total

1.  The synaptic vesicle protein synaptotagmin associates with calcium channels and is a putative Lambert-Eaton myasthenic syndrome antigen.

Authors:  C Leveque; T Hoshino; P David; Y Shoji-Kasai; K Leys; A Omori; B Lang; O el Far; K Sato; N Martin-Moutot
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 2.  Structural and functional maturation of active zones in large synapses.

Authors:  Raquel Cano; Laura Torres-Benito; Rocío Tejero; Anca I Biea; Rocío Ruiz; William J Betz; Lucía Tabares
Journal:  Mol Neurobiol       Date:  2012-09-20       Impact factor: 5.590

3.  Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.

Authors:  K L Engisch; M M Rich; N Cook; M C Nowycky
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

4.  Anesthetic management of a patient suspected of having Lambert-Eaton syndrome due to an unexpected prolongation of vecuronium.

Authors:  Kouichiro Minami; Takeyoshi Sata; Hiroshi Ishimura; Yuko Tomotari; Akio Shigematsu
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

5.  Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome.

Authors:  D O Smith; M W Conklin; P J Jensen; W D Atchison
Journal:  J Physiol       Date:  1995-08-15       Impact factor: 5.182

6.  Autonomic dysfunction in Lambert-Eaton myasthenic syndrome.

Authors:  S A Waterman
Journal:  Clin Auton Res       Date:  2001-06       Impact factor: 4.435

7.  Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission.

Authors:  Michael T Flink; William D Atchison
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

Review 8.  Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.

Authors:  Michael T Flink; William D Atchison
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

9.  Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer.

Authors:  P Maddison; B Lang; K Mills; J Newsom-Davis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-02       Impact factor: 10.154

10.  Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line.

Authors:  R G Smith; M E Alexianu; G Crawford; O Nyormoi; E Stefani; S H Appel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.